Back to top

Is This the Top for ArthroCare (ARTC)?

Read MoreHide Full Article
Although ArthroCare Corporation is up over 23.6% in the past four weeks, investors may be concerned. After all, ARTC is now in overbought territory, at least when looking at its RSI value of 71.7. If that wasn’t enough, investors should also note that ArthroCare possesses a Zacks Rank #4 (Sell), so if analyst perception is any guide, we could witness a slump in ARTC shares before too long.

Normally $25 each - click below to receive one report FREE:

More from Zacks Tale of the Tape

You May Like